The BMJ Today: Ebola and the importance of taking a travel history

The new cases of Ebola virus disease reported in Spain and the United States in recent days have reminded healthcare workers around the world to be vigilant for the infection. Several weeks ago, we spoke to Nick Beeching, senior lecturer and consultant in infectious disease at the Liverpool School of Tropical Medicine, about the UK’s […]

Read More…

The BMJ Today: Antidepressants, FDA warnings, and suicide under the microscope . . . again

For those who like “journalology,” today’s The BMJ has many of the ingredients for a rich case study. The latest published letters to the editor are dominated by those taking issue with a previously published research paper. The paper at issue—published this June and authored by Lu and colleagues—probed whether the Food and Drug Administration’s (FDA) 2003-04 […]

Read More…

The BMJ Today: Guidelines—comfort in a sea of uncertainty?

We’ve just published two more summaries of recommendations from the National Institute for Health and Care Excellence. We hope that these help our busy clinician readers get to grips fast with current best practice, especially where uncertainty or controversy exists. Both these summaries cover the latest you should know on diagnosis and management; one concerns […]

Read More…

The BMJ Today: Climate change and conflicts of interest: the sound and the fury

“Fury as top medical journal joins the green bandwagon” fumed the Daily Mail last week, which took exception to The BMJ’s publication of an article that, in the words of editor in chief Fiona Godlee, was not medicine or health but “pure climate science.” “In this unequal battle with big business and political inertia we have […]

Read More…

The BMJ Today: More on climate change

Earlier this year, The BMJ’s editor in chief, Fiona Godlee, was one of 50 senior UK medical professionals to sign a letter in the Times newspaper about the health benefits of ending investment in fossil fuels, and diverting funds instead to alternative energy and more active forms of transport. On 1 October 2014, The BMJ […]

Read More…

The BMJ Today: A new era in transparency

A new era in openness and transparency—and arguments over data—has begun with the publication of the first tranche of data made available under the US’s Sunshine Act. The act makes all drug, device, or biological manufacturers declare money they give to doctors (if it’s above $10), including cash in kind, i.e. food or drinks, even if […]

Read More…